Cancer treatment firm adding 27 jobs in Indianapolis
A North Carolina-based maker of cancer-fighting ultrasound machines plans to create 27 jobs paying an average of $36 an hour at its Indianapolis facility over the next three years.
Life Science & Biotech
Articles
VC funds hope to help early-stage life sciences firms
Early-stage venture capital has been harder and harder to come by for life sciences companies in recent years, but two Indianapolis investors are working to raise sizable funds to help fill the gap.
Cook wins approval for new stent
Bloomington-based Cook Medical won approval for the first drug-coated stent for clogged leg arteries in the United States, which accounts for 40 percent of the soon-to-be $3 billion market.
Indy loses promising health startup
LabDoor, which soon will launch an iPhone app that assigns A-F grades to over-the-counter vitamins and medicines, moved last month from Indianapolis to San Francisco, where it received $100,000 in startup financing.
Local scientific software firm plans to add 63 jobs
Indianapolis-based Indigo Biosystems Inc., a scientific software provider, announced Monday morning that it plans to add 63 jobs by 2015 as part of a $1.4 million expansion.
Life sciences finance pro heading to startup
If a biotech startup were akin to a rock band, Kristin Sherman might be the keyboardist. She’s not front-and-center on the stage, but the ballad wouldn’t be as dynamic without her pounding the chords.
Community to commercialize innovations
Community Health Network thinks it can help patients, engage doctors and maybe even make some money by trying to turn ideas within its organization into commercial products, service and companies.
Life sciences logistics firm plans to add 108 workers
Indianapolis-based BioStorage Technologies Inc. is planning to add 108 jobs in the next five years as part of a $7 million expansion and is seeking financial incentives from the city for the second time in three years.
Lilly to spend $140M on new insulin cartridge plant
About 100 workers will staff the new plant, which will be constructed by spring 2014 and ready for operations in 2015. But only “some” of that number will be new hires.
Purdue researcher harbors high hopes for new venture
Pete Kissinger hopes Phlebotics will follow in the footsteps of another of his creations, Bioanalytical Systems Inc.
Life sciences leader juggles faith, science and business
BioCrossroads CEO David Johnson sees little conflict as he balances all three in promoting and investing in Indiana life sciences firms
Lilly plans expansion of local insulin plant
The Indianapolis-based drugmaker plans to expand its local insulin plants to make insulin cartridges to meet what it describes as growing demand in the United States.
Outlook gloomy for device investments
The amount of venture capital invested in medical-device and equipment companies nationally has declined each quarter this year, reaching levels not seen since 2004, according to data released Oct. 19 by the National Venture Capital Association and PricewaterhouseCoopers.
Profit falls at Dow AgroSciences even as sales rise
Strong demand from farmers boosted sales by 8 percent at Dow AgroSciences LLC in the third quarter, but continued investments in new technologies slashed profits by 16 percent.
Lilly CEO calls for life sciences research institute
Eli Lilly CEO John Lechleiter on Tuesday called for creation of a “world-class” research institute in Indianapolis to bring together scientists from universities and corporations to develop new medical therapies and companies.
Roche continues to restructure diabetes unit
Roche officials said last week that price competition and lower reimbursement rates are forcing it to make an unspecified number of cuts in its U.S. sales force and at its research and development hubs in Indianapolis and Germany.
DANZ: Indianapolis tech community should build momentum
More money, mentoring would add fuel to lively industry.
Indianapolis tech firms, hospitals discover mutual need
An initiative is matching tech entrepreneurs with hospital officials in the hope of solving health care problems.
Lilly stomach-cancer drug helps survival, study finds
Eli Lilly and Co. shares rose nearly 5 percent Monday morning after it said a study found that its experimental stomach-cancer drug helped patients with advanced disease live longer.
Evans to lead AIT again as CEO leaves company
Ron Thieme, who took over as president and CEO of AIT Laboratories during a management shakeup earlier this year, is leaving the company, the Indianapolis-based firm announced Monday morning.